Equities
PRTC:LSE
Health CarePharmaceuticals and Biotechnology
- Price (GBX)199.88
- Today's Change-9.12 / -4.36%
- Shares traded218.91k
- 1 Year change-11.95%
- Beta1.1859
Data delayed at least 20 minutes, as of Jun 24 2024 13:43 BST.
More ▼
Add to Your Watchlists
Add to Your Portfolio
Your alerts
You must be a registered user to save alerts. Please sign in or register.
- Add to watchlist
- Add to portfolio
- Add an alert
Forecasts data is unavailable for this security.
Consensus recommendation
- 15-Jun-23
- 14-Mar-24
- 18-Apr-24
- 16-May-24
- 20-Jun-24
Select bar for recommendation details.
| Recommendations | 20-Jun-24 | |
|---|---|---|
| Buy | 1 | |
| Outperform | 0 | |
| Hold | 0 | |
| Underperform | 0 | |
| Sell | 0 |
Share price forecast
The 2 analysts offering 12 month price targets for
| High | 200.4% | 627.84 |
| Med | 139.1% | 499.74 |
| Low | 78.2% | 372.43 |
Earnings history & estimates
| Average growth rate | -76.48% |
More ▼
Revenue history & estimates
| Average growth rate | -5.28% |
More ▼
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsem*nt or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.
